Literature DB >> 9125137

Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.

K Nakamura1, Y Nakazawa, K Ienaga.   

Abstract

Vesperlysines A and B, 6-hydroxy-1,4-di{6-(L-norleucyl)}-1H-pyrrolo[3,2-b]pyridinium and its 5-methyl derivative, respectively, and Vesperlysine C, 5-hydroxy-methyl-1,6-di{6-(L-norleucyl)}-1H-pyrrolo[3,4-b] pyridinium, are isolated as major fluorescent advanced glycation end products (AGEs) from hydrochloric acid hydrolysis of AGE-BSA, bovine serum albumin (BSA) modified by the Maillard reaction with glucose. These fluorophores are glycation products and not artifacts of hydrolysis, since they are also detected in the reaction mixture of lysine and glucose prior to hydrolysis. Vesperlysines are crosslinked products from two lysine side-chains in proteins and are considered to be generated from lysines and the oxidative degradation of glucose, because the six carbon skeleton of glucose in its original form was not incorporated into each structure. These compounds are most likely glycoxidation products like pentosidine. This reasoning is supported by the formation of the same compounds in the Maillard reactions in which ascorbic acid or other sugars with shorter carbon chains are used.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125137     DOI: 10.1006/bbrc.1997.6262

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

2.  Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells.

Authors:  André K Langer; H Fai Poon; Gerald Münch; Bert C Lynn; Thomas Arendt; D Allan Butterfield
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

Review 3.  The role of the collagen matrix in skeletal fragility.

Authors:  Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2007-06       Impact factor: 5.096

4.  Partial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease.

Authors:  David R Sell; Ina Nemet; Vincent M Monnier
Journal:  Arch Biochem Biophys       Date:  2009-10-30       Impact factor: 4.013

5.  Association of glycemic profiles with whole blood polyamine among middle-aged Japanese men: colorimetric assay using oat and barley seedling polyamine oxidase.

Authors:  Takaaki Kondo; Kanami Yamamoto; Akiko Kimata; Jun Ueyama; Yoko Hori; Kenji Takagi
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

Review 6.  Pathways of the Maillard reaction under physiological conditions.

Authors:  Christian Henning; Marcus A Glomb
Journal:  Glycoconj J       Date:  2016-06-13       Impact factor: 2.916

7.  Advanced Glycation End-products and Bone Fractures.

Authors:  Deepak Vashishth
Journal:  IBMS Bonekey       Date:  2009-08

8.  Isolation and characterization of advanced glycation end products derived from the in vitro reaction of ribose and collagen.

Authors:  R G Paul; N C Avery; D A Slatter; T J Sims; A J Bailey
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 9.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus.

Authors:  M Saito; K Marumo
Journal:  Osteoporos Int       Date:  2010-02       Impact factor: 4.507

Review 10.  Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.

Authors:  Lamya Karim; Mary L Bouxsein
Journal:  Bone       Date:  2015-07-23       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.